Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What can RG say about M&A?

What can RG say about M&A?

posted on Jun 16, 2008 05:15PM

From the letter.

<We are making good progress in identifying, assessing and positioning future M&A transactions as I will outline in more detail in my shareholder letter later this month. >

You'd think he would know by now not to bring this subject up again and not say anything new. The words concerning M&A have gotten quite old. Looking, identifying, narrowing, researching, assessing, positioning bla bla bla..... He still doesn't have enough $$ to do anything significant IMHO. So what is he planning to tell us that we haven't already heard too many times already? God help him if he just rephrases and rehashes.

But then, maybe I'm wrong about the $$ thing. Perhaps the reason he talks like it's not a problem is because it really isn't. And what about the use of the plural - transactions? Contemplating more than one is he? Now who's dilusional? Opty



Share
New Message
Please login to post a reply